Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study
- PMID: 11306522
- DOI: 10.1161/01.cir.103.15.1949
Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study
Abstract
Background: Carriers of the apolipoprotein A-I(Milano) (apoA-I(M)) mutant present with very low plasma HDL cholesterol and moderate hypertriglyceridemia, apparently not leading to premature coronary heart disease. The objective of this study was to establish whether this high-risk lipid/lipoprotein profile is associated with structural changes in the carotid arteries and heart, indicative of preclinical atherosclerosis.
Methods and results: Twenty-one A-I(M) carriers were compared with age- and sex-matched control subjects from the same kindred and with 2 series of matched subjects with primary hypoalphalipoproteinemia (HA). Structural changes in the carotid arteries were defined as the intima-media thickness (IMT) measured by B-mode ultrasound. HA subjects, both recruited among patients attending our Lipid Clinic and blood donors, showed significant thickening of the carotids (average IMT, 0.86+/-0.25 and 0.88+/-0.29 mm, respectively) compared with control subjects (average IMT, 0.64+/-0.12 mm); the apoA-I(M) carriers instead showed normal arterial thickness (average IMT, 0.63+/-0.10 mm). Moreover, a significantly higher prevalence of atherosclerotic plaques was found in patients and blood donors with HA (both 57%) compared with apoA-I(M) carriers (33%) and control subjects (21%). Echocardiographic findings and maximal treadmill ECG did not differ significantly between apoA-I(M) carriers and control subjects, apart from a slight increase in left ventricular end-diastolic dimension in the carriers.
Conclusions: Despite severe HA, carriers of the apoA-I(M) mutant do not show structural changes in the arteries and heart, in contrast to HA subjects, who are characterized by a marked increase in carotid IMT and increased prevalence of atherosclerotic plaques.
Similar articles
-
Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.J Clin Endocrinol Metab. 2001 Mar;86(3):1061-5. doi: 10.1210/jcem.86.3.7268. J Clin Endocrinol Metab. 2001. PMID: 11238486
-
Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly.Clin Endocrinol (Oxf). 2001 Apr;54(4):515-24. doi: 10.1046/j.1365-2265.2001.01256.x. Clin Endocrinol (Oxf). 2001. PMID: 11318788
-
Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.Circulation. 2007 Nov 6;116(19):2165-72. doi: 10.1161/CIRCULATIONAHA.107.705657. Epub 2007 Oct 22. Circulation. 2007. PMID: 17967773
-
[Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint].Ultraschall Med. 2003 Jun;24(3):162-74. doi: 10.1055/s-2003-40058. Ultraschall Med. 2003. PMID: 12817310 Review. German.
-
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases.Curr Atheroscler Rep. 2006 Mar;8(2):163-7. doi: 10.1007/s11883-006-0054-4. Curr Atheroscler Rep. 2006. PMID: 16510051 Review.
Cited by
-
HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.J Lipid Res. 2015 Oct;56(10):2002-9. doi: 10.1194/jlr.M059865. Epub 2015 Aug 7. J Lipid Res. 2015. PMID: 26254308 Free PMC article.
-
Probing the Structure-Function relationship and amyloidogenic propensities in natural variants of apolipoprotein A-I.Biochem Biophys Rep. 2020 Sep 29;24:100815. doi: 10.1016/j.bbrep.2020.100815. eCollection 2020 Dec. Biochem Biophys Rep. 2020. PMID: 33024841 Free PMC article.
-
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.Curr Atheroscler Rep. 2022 Jul;24(7):585-597. doi: 10.1007/s11883-022-01025-7. Epub 2022 May 7. Curr Atheroscler Rep. 2022. PMID: 35524914 Free PMC article. Review.
-
HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?Curr Cardiol Rep. 2018 Jun 21;20(8):66. doi: 10.1007/s11886-018-1004-9. Curr Cardiol Rep. 2018. PMID: 29926215 Free PMC article. Review.
-
Connecting Cholesterol Efflux Factors to Lung Cancer Biology and Therapeutics.Int J Mol Sci. 2021 Jul 5;22(13):7209. doi: 10.3390/ijms22137209. Int J Mol Sci. 2021. PMID: 34281263 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical